They target the same outcome (tissue repair) through different mechanisms : BPC-157: local growth factor expression, fibroblast stimulation, angiogenesis at the injury site TB-500: systemic cell migration, actin regulation, reduction of chronic inflammation throughout the body Standard Wolverine stack: BPC-157: 250500 mcg SC twice daily , injected near the injury site where possible TB-500: 22.5 mg SC twice weekly loading (weeks 14), then 2 mg weekly maintenance (weeks 512) CRITICAL: do not mix in the same vial - they can be injected in the same session but must remain in separate solutions
Thats inflammation talking
Will continue purchasing as the benefits are amazing
The compound cannot be misbranded, mislabeled or misused for any non-research applications
Save $10 Sale
It is not FDA-approved as of April 2026, is not formulated for human consumption or veterinary use, and cannot be legally used to treat, diagnose, or cure any disease